NCT03632473View on ClinicalTrials.gov

Validation of Multimodal Evoked Potentials (mmEP) for Predicting Disease Progression in Multiple Sclerosis

CompletedOBSERVATIONAL
Enrollment

29

Participants

Timeline

Start Date

August 28, 2014

Primary Completion Date

June 26, 2020

Study Completion Date

June 26, 2020

Conditions
Multiple Sclerosis
Interventions
DIAGNOSTIC_TEST

multimodal evoked potentials (mmEP)

combination of visual evoked potentials (VEP) and motor evoked potentials (MEP) or the combination of VEP, MEP and somato-sensory evoked potentials (SSEP)

Trial Locations (3)

4031

Dep. of Neurology, Hospital of the University of Basel, Basel

6903

Neurocenter of Southern Switzerland, Ospedale Regionale di Lugano, Lugano

Unknown

Hopitaux universitaires de Genève, Geneva

All Listed Sponsors
lead

University Hospital, Basel, Switzerland

OTHER

NCT03632473 - Validation of Multimodal Evoked Potentials (mmEP) for Predicting Disease Progression in Multiple Sclerosis | Biotech Hunter | Biotech Hunter